Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Affinivax on the deal. Affinivax, a clinical stage biopharmaceutical company, announced its $226 million Series C financing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
